000 02349 a2200637 4500
005 20250517072927.0
264 0 _c20161213
008 201612s 0 0 eng d
022 _a1473-4877
024 7 _a10.1185/03007995.2016.1140028
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVogelzang, Nicholas J
245 0 0 _aComparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart review.
_h[electronic resource]
260 _bCurrent medical research and opinion
_c2016
300 _a741-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAxitinib
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aComparative Effectiveness Research
650 0 4 _aDisease-Free Survival
650 0 4 _aEverolimus
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xadministration & dosage
650 0 4 _aIndazoles
_xadministration & dosage
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNiacinamide
_xadministration & dosage
650 0 4 _aPhenylurea Compounds
_xadministration & dosage
650 0 4 _aProportional Hazards Models
650 0 4 _aProtein Kinase Inhibitors
_xadministration & dosage
650 0 4 _aPyrimidines
_xadministration & dosage
650 0 4 _aPyrroles
_xadministration & dosage
650 0 4 _aRetrospective Studies
650 0 4 _aSirolimus
_xadministration & dosage
650 0 4 _aSorafenib
650 0 4 _aSulfonamides
_xadministration & dosage
650 0 4 _aSunitinib
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
700 1 _aPal, Sumanta K
700 1 _aSignorovitch, James E
700 1 _aReichmann, William M
700 1 _aLi, Nanxin
700 1 _aYang, Chelsey
700 1 _aLiu, Zhimei
700 1 _aPerez, Jose Ricardo
700 1 _aJonasch, Eric
773 0 _tCurrent medical research and opinion
_gvol. 32
_gno. 4
_gp. 741-7
856 4 0 _uhttps://doi.org/10.1185/03007995.2016.1140028
_zAvailable from publisher's website
999 _c25611760
_d25611760